VEGF-Trap: A VEGF blocker with potent antitumor effects
Jocelyn Holash(Regeneron (United States)), John S. Rudge(Regeneron (United States)), Tom Daly(Regeneron (United States)), Donna Hylton(Regeneron (United States)), Michelle Russell(Regeneron (United States)), James P. Fandl(Regeneron (United States)), Ella Ioffe(Regeneron (United States)), Susan D. Croll(Regeneron (United States)), Tammy Huang(Regeneron (United States)), Stanley J. Wiegand(Regeneron (United States)), Elena Burova(Regeneron (United States)), Patricia Boland(Regeneron (United States)), Kevin M. Bailey(NOAA National Marine Fisheries Service Alaska Fisheries Science Center), Czeslaw Radziejewski(Regeneron (United States)), Sam Davis(Regeneron (United States)), Lillian Ho(Regeneron (United States)), George D. Yancopoulos(Regeneron (United States)), Ray Leidich(Regeneron (United States))
Cited by 1,679
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
Regulation of the Germinal Center Response by MicroRNA-155
|Science|2007|1.5k
Angiopoietin-1 protects the adult vasculature against plasma leakage
|Nature Medicine|2000|1.3k
Evinacumab for Homozygous Familial Hypercholesterolemia
|New England Journal of Medicine|2020|763